Amgen Inc. Restructuring Reserve
Amgen Inc. (AMGN) had Restructuring Reserve of $132.00 million as of 2023-03-31, per its 10-Q filed 2023-04-28.
Discontinued › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2023-04-28
- 2023-03-31: Restructuring Reserve $132.00M.
- 2017-12-31: Restructuring Reserve $68.00M.
- 2016-12-31: Restructuring Reserve $20.00M.
- 2016-06-30: Restructuring Reserve $35.00M.
| Period end | Restructuring Reserve |
|---|---|
| 2023-03-31 | $132.00M 10-Q · filed 2023-04-28 |
| 2017-12-31 | $68.00M 10-K · filed 2018-02-13 |
| 2016-12-31 | $20.00M 10-K · filed 2018-02-13 |
| 2016-06-30 | $35.00M 10-Q · filed 2016-07-29 |
| 2016-03-31 | $38.00M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $118.00M 10-K · filed 2018-02-13 |
| 2015-09-30 | $120.00M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $159.00M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $192.00M 10-Q · filed 2015-04-27 |
| 2014-12-31 | $244.00M 10-K · filed 2018-02-13 |
| 2014-09-30 | $311.00M 10-Q · filed 2014-10-29 |
| 2014-06-30 | $0.00 10-Q · filed 2014-10-29 |
| 2013-12-31 | $0.00 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |